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Abstract
Background: Cardiac resynchronization therapy (CRT) has been shown to reduce heart
failure-related morbidity and mortality. However, approximately one in three patients do not
respond to CRT. The aim of the current study was to determine the parameter(s) which predict
reverse remodeling and clinical improvement after CRT.
Methods: A total of 54 patients (43 male, 11 female; mean age 61.9 ± 10.5 years) with heart
failure and New York Heart Association (NYHA) class III–IV symptoms and in whom left
ventricular ejection fraction (LVEF) was £ 35% and QRS duration was ≥ 120 ms, despite
optimal medical therapy, were enrolled. An echocardiographic examination was performed
before, and six months after, CRT. An echocardiographic response was defined as a reduction
of end-systolic volume ≥ 10% after six months, and a clinical response was defined as
a reduction ≥ 1 in the NYHA functional class score.
Results: An echocardiographic response was observed in 38 (70.4%) of the patients and
a clinical response occurred in 41 (75.9%) of the patients. Of the dyssynchrony parameters,
only the aortic pre-ejection interval (APEI) was observed to significantly predict the clinical
response (p = 0.048) and echocardiographic response (p = 0.037). A 180.5 ms cut-off value
for the APEI predicted the clinical response with a sensitivity of 92.3% and a specificity of
39%, and the echocardiographic response with a sensitivity of 93.0% and a specificity of 42%.
Conclusions: APEI derived from pulsed-wave Doppler, which is available in every echocardio-
graphy machine, is a simple and practical method that could be used to select patients for CRT.
(Cardiol J 2011; 18, 6: 639–647)
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Introduction
Intraventricular conduction abnormalities con-
comitant with systolic dysfunction are frequently
encountered in patients with heart failure (HF). Of
all patients with HF, 25–50% have a QRS duration
> 120 ms and 15–27% have a left bundle branch
block [1]. Delayed conduction in patients with di-
lated cardiomyopathy leads to abnormal depolariza-
tion of the ventricles, inter- and intra-ventricular
contraction and relaxation dyssynchrony, increased
regional and global wall stress, as well as decreased
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effective ejection time and stroke volume [2, 3].
Consequently, impaired synchronization results in
poor ventricular function, remodeling of the left
ventricle, and HF, which triggers a pathophysiologic
process with increased morbidity and mortality.
Cardiac resynchronization therapy (CRT) im-
proves functional capacity, left ventricular (LV)
systolic, diastolic and autonomic functions, and sur-
vival, in patients with refractory HF and left bun-
dle branch block [4–7]. Multicenter, randomized,
double-blind trials such as COMPANION [8] and
CARE-HF [4] have demonstrated that CRT im-
proves symptoms and exercise capacity, while
shortening hospitalization for patients who, despite
optimal medical therapy, have symptoms consistent
with New York Heart Association (NYHA) class
III–IV, with a QRS duration of ≥ 120 ms and a de-
creased left ventricular ejection fraction (LVEF).
Although CRT is a positive approach in de-
creasing mortality and morbidity in patients with
advanced stage HF, 25% of patients fail to demon-
strate an improvement in symptoms following CRT.
Consequently, evaluating synchronization impair-
ment before administering CRT can be useful in
determining those patients who are likely to bene-
fit from the procedure [4–7].
The aim of the present study was to estab-
lish the optimal echocardiographic parameter(s)
in patient selection and evaluation of the response
to CRT.
Methods
Study population
Sixty-three patients with symptoms of NYHA
class III–IV HF, a LVEF £ 35%, sinus rhythm, and
a QRS duration ≥ 120 ms, despite optimal medical
therapy, who were admitted to our department be-
tween December 2007 and May 2009, were enrolled
in the study. Four of the 63 could not undergo CRT
implantation owing to inappropriate coronary sinus
(CS) anatomy. In addition, three patients were ex-
cluded from the study because they did not attend
follow-up visits, and two patients were excluded be-
cause of poor echogenicity. The remaining 54 pa-
tients (43 males and 11 females; mean age ± SD:
61.9 ± ± 10.5 years) were evaluated in terms of
age, gender, coronary artery disease (CAD) histo-
ry, diabetes mellitus (DM), hyperlipidemia, hyper-
tension (HT), and other related diseases. All pa-
tients were also examined with respect to their
functional capacities. All patients underwent a com-
plete physical examination, and their height and
weight were recorded. All patients also underwent
12-lead electrocardiography. The patients underwent
a detailed echocardiographic examination twice:
once at baseline and again six months after CRT.
Patients were excluded if they had been admit-
ted with acute coronary syndrome in the last three
months, required continuous or intermittent intra-
venous inotropic drugs, had a life expectancy of
< six months, had a history of pacemaker implan-
tation, mechanical tricuspid valve, heart transplan-
tation, or electrical storm. Informed consent was ob-
tained from all patients and the study was approved
by the Hospital Ethics Committee.
Echocardiographic evaluation
The patients underwent transthoracic echocar-
diography at baseline and again six months after
CRT implantation. Echocardiographic examination
was performed in the left lateral position using
Vingmed System Five GE Ultrasound (General
Electric, Horten, Norway) with a 2.5–3.5 MHz
transducer from parasternal long- and short-axes,
and apical two- and four-chamber views. The mea-
surements were based on the criteria set out by the
American Society of Echocardiography. The pa-
tients underwent M-mode echocardiography, two-
-dimensional (2D) echocardiography, pulsed wave
(PW) Doppler, color Doppler, and PW and color tis-
sue Doppler imaging. From the parasternal long
axis, the left ventricular end-diastolic diameter
(LVEDD) and the left ventricular end-systolic dia-
meter (LVESD) were measured using M-mode (at
the mitral chordal level perpendicular to the long
axis of the ventricle). Then the LVEF was calculat-
ed. The endocardial boundaries were identified us-
ing end-diastolic and end-systolic images from the
apical four-chamber view, and the left ventricular
end-diastolic volume (LVEDV) and left ventricular
end-systolic volume (LVESV) and LVEF were cal-
culated with the modified Simpson’s method [9]. In
the parasternal short axis, the sequence between
the contractions of septal and posterior walls at the
level of the papillary muscle was measured as the
septal-to-posterior wall motion delay (SPWMD).
A sequence > 130 ms was regarded as an indicator
of intraventricular dyssynchrony [10].
The intervals between the onset of QRS to the
beginning of ejection at the aortic and pulmonary
valve levels using PW Doppler were defined as the
aortic pre-ejection interval (APEI) and the pulmo-
nary pre-ejection interval (PPEI), respectively. An
APEI value ≥ 140 ms reflects prolonged LV acti-
vation, dyssynchrony and delayed LV ejection [11].
Interventricular mechanical delay (IVMD) was de-
fined as the difference between APEI and PPEI. An
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IVMD value ≥ 40 ms is regarded as an indicator of
interventricular dyssynchrony [10].
PW tissue Doppler (PWTD) (during echocar-
diography [real-time]) was performed at the septum
distal to the point where the septal leaflet of the
mitral valve was adherent to the annulus (basal sep-
tum) and at the lateral basal segments. Using
PWTD, the interval between the QRS onset and the
onset of peak systolic velocity (Sm) was measured
by placing a sample volume of 10 mm width in the
septal and lateral mitral annulus at the apical four-
-chamber view. A delay ≥ 60 ms between the late-
ral wall and the septum was regarded as intraven-
tricular dyssynchrony [12].
Color tissue Doppler samples were recorded
from the apical two- and four-chamber views, en-
suring that they covered a minimum of three car-
diac cycles. The recordings were performed with
gray-scale 2D images at a frame rate of 150/s and
a depth of 10.8 mm. The recordings were per-
formed at the end of expiration to preclude inter-
ference from global cardiac movement. The sam-
ple volumes were placed on the basal segments of
the septal and lateral walls. The time elapsed be-
tween the peak velocities of the septum and late-
ral wall was calculated. An interval ≥ 65 ms was
regarded as intraventricular dyssynchrony [13].
EchoPAC 6.3.6 GE software was used for the cal-
culations.
Device implantation
Following creation of the pacemaker pocket
through a left pectoral incision, a left subclavian vein
puncture was performed. A defibrillation electrode
was placed in the apex of the right ventricle. After
CS cannulation, the CS and its branches were moni-
tored using venography. The LV electrode was
placed in the posterolateral branch of the CS in
50 (92.5%) patients. It was placed in the antero-
lateral branch of the CS in the remaining four
(7.5%) patients. The electrodes were tested for
pacing and sensing characteristics. All implanted
biventricular pacemakers also had the feature of
working as a defibrillator. Atrioventricular delay
was optimized using 2D echocardiography follow-
ing implantation.
Definition of the response
A decrease of ≥ 10% in LVESV at six month
follow-up was defined as echocardiographic re-
sponse [14]. Clinical response was defined as a de-
crease by ≥ 1 in the NYHA functional class score
[5, 6].
Statistical analysis
Numerical variables with a normal distribution
were expressed as mean ± SD, and numerical varia-
bles without a normal distribution were expressed
as the median with minimum and maximum values.
Categorical variables were expressed in percenta-
ges. A Pearson c2 test was used to compare the two
groups in the study. A significance test was per-
formed for differences between the groups with
respect to the mean values. The patients who were
under or above the cut-off points were compared
using Fisher’s exact test. Inter-observer and intra-
observer agreements were assessed with intra- and
interclass correlation coefficient, and with the av-
erage difference between readings, corrected for
their mean (variability). Receiver operating chara-
cteristics (ROC) curve analysis was performed to
establish both the parameters that can best predict
the CRT response, and the best cut-off points for
those parameters. SPSS 15.0 statistical analysis
software (SPSS Inc., Chicago, IL, USA) was used
to evaluate variables and tests. A p value < 0.05
was considered significant.
Results
Patient characteristics
Fifty-four patients (43 males and 11 females;
mean age ± SD: 61.9 ± 10.5 years) with complete
baseline echocardiographic measurements, dyssyn-
chrony analysis, and follow-up records concerning
left ventricle volume and ejection fraction values,
were enrolled in the study.
Of the patients, 40 (74.1%) had HT, 19 (35.2%)
had DM, 39 (72.2%) had hyperlipidemia, and 38
(70.4%) had a history of CAD. Drug therapies used
by the patients were similar before and after CRT.
The patients’ characteristics are presented in Table 1.
The QRS duration, as well as LVEDD, LVESV, and
LVEF, measured using the modified Simpson’s
method, were shown to have improved significant-
ly at the six month follow-up (Table 2).
An echocardiographic response, defined as
a decrease of ≥ 10% in LVESV, was observed in
38 (70.4%) patients. A clinical response, defined as
a decrease of  ≥ 1 in NYHA functional class score,
was observed in 41 (75.9%) patients.
Reproducibility
For intra-observer reliability analysis, a sam-
ple of 15 patients was re-analyzed over the 5–7 days
between first and second analysis. Intra-observer
correlation coefficient and variability for LVESV
642
Cardiology Journal 2011, Vol. 18, No. 6
www.cardiologyjournal.org
The inter-observer correlation coefficient and varia-
bility for SPWMD were 0.767 and 5.8%; for IVMD
were 0.732 and 7.2%, for APEI were 0.853 and
4.1%, for PW-TDI (lateral-septal delay) were 0.743
and 7.1%, for C-TDI (lateral-septal delay) were
0.798 and 5.7%,  respectively.
Clinical response
A comparison between patients with and with-
out a clinical response in terms of baseline demo-
graphic and echocardiographic values revealed that
CAD had a significantly higher incidence in patients
without a response (61.5 vs 93.3%, p = 0.020;
Table 3). LVEF values, measured using the modi-
fied Simpson’s method, were shown to have im-
proved significantly (p = 0.046).
Patients with a clinical response had a long-
er SPWMD, IVMD and APEI than the patients
without a clinical response. However, the differ-
ence was significant only with respect to the APEI
(Table 4).
Of the dyssynchrony parameters, only the
APEI was observed to significantly predict a clini-
cal response (p = 0.048) in the analysis comparing
patients meeting and failing to meet the cut-off va-
lues described in the literature, while the remain-
ing parameters did not reach statistical significance
(Table 5). The APEI was calculated to have a posi-
tive predictive value of 81.8% and a negative pre-
dictive value of 50%. ROC analysis revealed the
area under the curve (AUC) value of the APEI in
predicting clinical response to be 0.70 (p = 0.031)
(Fig. 1). The APEI, with a cut-off point of 180.5 ms,
was calculated to have 92.3% sensitivity and 39%
specificity in predicting the clinical response.
Echocardiographic response
A comparison between the patients observed
with and without an echocardiographic response
revealed no significant difference in terms of base-
Table 1. Baseline clinical and demographic
features of patients.
Age (years) 61.9 ± 10.5
Male 43 (79.6%)
Diabetes 19 (35.2%)
Hypertension 40 (74.1%)
Coronary artery disease 38 (70.4%)
QRS duration [ms] 146.64 ± 25.94
Left atrial diameter [cm] 4.47 ± 0.50
LV end-diastolic diameter [cm] 6.85 ± 0.76
LV end-systolic diameter [cm] 5.70 ± 0.73
LV end-diastolic volume [mL] 169.87 ± 47.11
LV end-systolic volume [mL] 128.09 ± 40.27
LV ejection fraction [%]* 24.68 ± 4.01
LV fractional shortening [%]** 12.39 ± 3.12
ACE-I or ARB use 54 (100%)
Beta-blocker use 48 (88.8%)
Diuretic use 54 (100%)
Digoxin use 42 (77.7%)
Spironolactone use 29 (53.7%)
Decline in LV end-systolic 38 (70.4%)
volume ≥ 10%
Numerical variables were presented as the mean ± standard deviation
and categorical variables were presented as percentages; *measured
by modified Simpson’s method; **measured by M-mode echocar-
diography; ACE-I — angiotensin converting enzyme inhibitors;
ARB — angiotensin receptor blockers; LV — left ventricular
Table 2. Comparison of clinical and echocardiographic parameters at baseline and six months after
cardiac resynchronization therapy (CRT).
Before CRT After CRT P
NYHA functional capacity 2.87 ± 0.58 1.90 ± 0.70 0.004
QRS [ms] 146.64 ± 25.94 132.96 ± 21.06 < 0.001
LVEDV [mL] 169.87 ± 47.11 154.87 ± 42.68 < 0.001
LVESV [mL] 128.09 ± 40.27 109.29 ± 37.56 < 0.001
LVEF (Simpson’s method) (%) 24.68 ± 4.01 30.24 ± 7.80 < 0.001
Numerical variables were presented as the mean ± standard deviation; LVEDV — left ventricular end-diastolic volume; LVESV — left ventricular end-
-systolic volume; LVEF — left ventricular ejection fraction
were 0.980 and 1.1%, and for LVEDV were 0.913
and 1.7%, respectively. The inter-observer corre-
lation coefficient and variability for LVESV were
0.921 and 1.6%, and for LVEDV they were 0.876
and 2.5%.
Intra-observer correlation coefficient and vari-
ability for SPWMD were 0.891 and 3.2%; for IVMD
they were 0.798 and 5.5%; for APEI they were 0.903
and 2.0%; for PW-TDI (lateral-septal delay) they
were 0.878 and 3.7%; and for C-TDI (lateral-septal
delay) they were 0.881 and 3.4%, respectively.
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Table 5. Comparison of dyssynchrony parameters in predicting the clinical and echocardiographic
response to cardiac resynchronization therapy.
Parameter Dyssynchrony Total Decrease of ≥ 1 P Decrease of ≥ 10 P
cut-off value  in NYHA class  in LVESV
SPWMD [ms]
≥ 130
+ 49 38 (77.6%)
0.347
35 (71.4%)
0.468
– 5 3 (60%) 3 (60%)
IVMD [ms]
≥ 40
+ 36 27 (75%)
0.552
23 (63.9%)
0.122
– 18 14 (77.8%) 15 (83.8%)
APEI [ms]
≥ 140
+ 44 36 (81.8%)
0.048
34 (77.2%)
0.037
– 10 5 (50%) 4 (40%)
PW-TDI (lateral-
≥ 60
+ 42 30 (71.4%)
0.143
29 (69%)
0.496-septal delay) [ms] – 12 11 (91.7%) 9 (75%)
C-TDI (lateral-
≥ 65
+ 49 38 (77.6%)
0.347
33 (63.7%)
0.159-septal delay) [ms] – 5 3 (60%) 5 (100%)
NYHA — New York Heart Association; LVESV — left ventricular end-systolic volume; SPWMD — septal-to-posterior wall motion delay; IVMD — interven-
tricular mechanical delay; APEI — aortic pre-ejection interval; PW-TDI — pulse-wave tissue Doppler imaging; C-TDI — color-coded tissue Doppler imaging
Table 4. Comparison of dyssynchrony parameter times in patients with respect to clinical or
echocardiographic response to cardiac resynchronization therapy.
Clinical Clinical P Echocardio- Echocardio- P
response (+) response (–) graphic graphic
response (+) response (–)
n = 41 (75.9%)   n = 13 (24.1%) n = 38 (70.4%)   n = 16 (29.6%)
SPWMD [ms] 204.35 ± 54.81 188.00 ± 65.70 0.357 209.47 ± 59.72 176.87 ± 47.28 0.040
IVMD [ms] 48.10 ± 21.39 45.93 ± 24.85 0.751 44.50 ± 20.68 54.62 ± 24.64 0.127
APEI [ms] 171.15 ± 31.58 145.20 ± 32.96 0.010 170.42 ± 32.70 148.56 ± 32.12 0.028
PW-TDI (lateral- 77.92 ± 33.40 78.20 ± 19.26 0.976 77.55 ± 33.65 79.06 ± 19.46 0.837
-septal delay) [ms]
C-TDI (lateral- 82.30 ± 22.84 87.66 ± 25.60 0.459 83.55 ± 24.96 84.37 ± 20.44 0.908
-septal delay) [ms]
Numerical variables were presented as the mean ± standard deviation; SPWMD — septal-to-posterior wall motion delay; IVMD — interventricular
mechanical delay; APEI — aortic pre-ejection interval; PW-TDI — pulse-wave-tissue Doppler imaging; C-TDI — color-tissue Doppler imaging
Table 3. Comparison of demographic and echocardiographic data of patients with and without clinical
response or echocardiographic response to cardiac resynchronization therapy.
Parameter Clinical Clinical P Echocardio- Echocardio- P
response (+) response (–) graphic graphic
response (+) response (–)
Age (years) 61.1 ± 10.4 64.4 ± 10.8 NS 61.8 ± 10.3 62.3 ± 11.3 NS
Male 30 (76.9%) 13 (86.7%) NS 28 (73.7%) 15 (93.8%) NS
Diabetes mellitus 33.3% 40% NS 36.8% 31.3% NS
Hypertension 69.2% 86.7% NS 76.3% 68.8% NS
Coronary artery disease 61.5% 93.3% 0.020 63.2% 87.5% 0.048
Baseline QRS [ms] 146.04 ± 26.77 148.53 ± 24.07 NS 147.00 ± 24.75 145.81 ± 29.42 NS
QRS (follow-up) [ms] 132.12 ± 21.82 135.61 ± 19.05 NS 131.92 ± 18.43 135.43 ± 26.84 NS
LVEDV [mL] 169.78 ± 46.34 170.15 ± 51.42 NS 166.84 ± 49.55 177.06 ± 41.29 NS
LVEDV (follow-up) [mL] 153.19 ± 41.69 160.15 ± 47.01 NS 147.15 ± 42.48 173.18 ± 38.41 0.035
LVESV [mL] 127.92 ± 39.34 128.61 ± 44.73 NS 125.68 ± 42.51 133.81 ± 34.94 NS
LVESV (follow-up) [mL] 106.85 ± 37.54 117.00 ± 38.07 NS 101.18 ± 37.60 128.56 ± 30.59 0.013
LVEF (%)* 24.90 ± 3.75 24.00 ± 4.86 NS 25.07 ± 4.25 23.75 ± 3.33 NS
LVEF (follow-up) (%)* 31.26 ± 8.13 27.00 ± 5.78 0.046 32.15 ± 8.30 25.68 ± 3.75 0.004
Numerical variables were presented as the mean ± standard deviation; *measured by modified Simpson’s method; LVEDV — left ventricular end-
-diastolic volume; LVESV — left ventricular end-systolic volume; LVEF — left ventricular ejection fraction
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line demographic and echocardiographic data, ex-
cept for the presence of CAD. While 63.2% of the
patients with an echocardiographic response had
CAD, 87.5% of the patients with no response had
CAD (p = 0.048). Significant improvements were
determined in the follow-up period in LVEDV,
LVESV, and LVEF values measured using the modi-
fied Simpson’s method (Table 3).
Comparing dyssynchrony parameters in the
patients with and without an echocardiographic re-
sponse demonstrated that the patients with a re-
sponse had a longer SPWMD and APEI. These dif-
ferences were statistically significant with respect
to both parameters (Table 4).
Among the dyssynchrony parameters, only the
APEI was observed to significantly predict the
echocardiographic response, defined as a decrease
≥ 10% in the LVESV (p = 0.037) (Table 5).
ROC analysis revealed that the APEI had an AUC
value of 0.668 (p = 0.048) in predicting the echocar-
diographic response (Fig. 2). The APEI, with a cut-
-off point of 180.5 ms, was established to have 93%
sensitivity and 42% specificity in predicting the
echocardiographic response.
Discussion
Echocardiography has been proposed as an ef-
fective method of selecting patients eligible for CRT
[15], although opinions on this issue still differ.
PROSPECT, a recently published trial, was designed
to investigate the adequacy of echocardiographic
parameters in determining the CRT response. It
concluded that the selection of patients for CRT is
not based solely on echocardiographic parameters,
whereas the fundamental selection criterion in the
evaluation of dyssynchrony is QRS width [10].
On the other hand, our study found that the APEI is
a predictor of clinical and echocardiographic response
following CRT. However, SPWMD, IVMD, PW, and
color tissue Doppler parameters were observed to
be inadequate in predicting the clinical and echocar-
diographic response.
Since the responses of patients to CRT vary,
the patients were divided into two groups based on
the improvements in NYHA functional classification
and reverse remodeling of the LV, referred to as
the ‘responding’ and ‘non-responding’ patients.
Several studies have defined the criteria for
response to therapy as a decrease of ≥ 1 in NYHA
functional class or a decrease of ≥ 10% in LVESV
[14, 16]. Bax et al. [13] reported in their study that
31% of patients failed to achieve a clinical response.
PROSPECT  reported that 69% of the patients im-
proved, 15% remained unaltered, and 16% deterio-
rated [10]. In our study, 41 (75.9%), of the patients
were found to be responding to therapy clinically,
consistent with the results of previous studies. Yu
et al. [14] evaluated 141 patients undergoing CRT
implantation and maintained a decrease of ≥ 10%
in LVESV at six month follow-up to be the most
important predictor of death for all causes and car-
diovascular death.
In the present study, setting the criterion for
echocardiographic therapy response as a decrease
of ≥ 10% in LVESV, 38 (70.4%) patients were
Figure 1. Receiver operating characteristics analysis
for aortic pre-ejection interval in predicting clinical
response.
Figure 2. Receiver operating characteristics analysis
for aortic pre-ejection interval in predicting echo-
cardiographic response.
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judged to have responded to therapy. The higher
rate observed in the present study compared to the
previous studies may be attributed to the fact that
the other studies defined therapeutic response as
a decrease of ≥ 15% in LVESV [17, 18]. Moreover,
the ideal end-point to assess the response to CRT
remains unclear, and there are differences in clini-
cal and echocardiographic response rates [19].
M-mode indices
The first to be developed, and still the simplest,
echocardiographic method for evaluating dyssyn-
chrony is SPWMD. In the study by Pitzalis et al.
[20] conducted on 20 patients, it was reported that
SPWMD predicted LV reverse remodeling. A more
recent study by Pitzalis et al. [21] suggested that
a longer SPWMD is associated with decreased risk
in the progression of HF. However, both studies had
high percentages of patients with non-ischemic car-
diomyopathy (78%). Retrospective analysis of the
79 patients in the CONTAK-CD trial demonstrat-
ed that SPWMD failed to predict the clinical and
echocardiographic responses. Of the patients in the
trial, 72% had ischemic cardiomyopathy. However,
the analysis performed on the patients with non-
-ischemic cardiomyopathy did not establish SPWMD
to have any predictive value [22].
A major restriction on SPWMD measurement
is the presence of regional wall motion abnormali-
ties. The measurements are unreliable, particular-
ly in patients in whom the anterior septum is aki-
netic. Consequently, the reliability of SPWMD in
predicting the response to CRT is decreased.
According to the results obtained in the present
study, SPWMD could not predict either echocardio-
graphic or clinical response. One reason why
SPWMD poorly predicts the CRT response may be
the high ratio of CAD in our patient population
(70.4%). However, we found that patients with an
echocardiographic response had a longer SPWMD
than non-responders. Although there are conflict-
ing results in the literature concerning this parti-
cular parameter, it is an easily measured index of
radial dyssynchrony which should be measured and
carefully analyzed in all patients.
Pulse-wave Doppler indices
The APEI is a combined electromechanical in-
dex wherein higher values reflect prolonged LV
activation, LV dyssynchrony and delayed ejection
[11]. It is easily obtained by measuring the time
interval between the beginning of the QRS complex
and the onset of transaortic ejection. St John Sut-
ton et al. [23] reported that an APEI > 160 ms was
an independent predictor of the CRT response.
Wiesbauer et al. [24] maintained that an APEI with
a cut-off value of 140 ms predicted the clinical and
echocardiographic responses. The PROSPECT trial
also reported that prolonged APEI was associated
with clinical and echocardiographic responses [10].
In the current study, it was determined that the
baseline APEI were significantly longer in the clini-
cal and echocardiographic responding groups com-
pared to the non-responding group. ROC analysis
showed that the APEI with a cut-off point of 180.5 ms
predicted the clinical response with 92.3% sensi-
tivity and 39% specificity, while it had 93% sensi-
tivity and 42% specificity in predicting the echocar-
diographic response. Contradicting these results,
a recent study by Bordachar et al. [25] could not find
any statistically significant role of APEI in predict-
ing response to CRT.
It has been reported that IVMD, with a cut-off
point varying between 40–60 ms, predicts the re-
sponse to CRT [26, 27]. Da Costa et al. [28] also
reported IVMD values > 50 ms to be the only dys-
synchrony parameter predicting a positive response
to CRT. Richardson et al. [26] stated in the analy-
sis performed for the CARE-HF trial that a cut-off
value of 50 ms predicted survival. Similarly, the
PROSPECT trial reported that IVMD, with a cut-
-off value of 40 ms, predicted the clinical and
echocardiographic responses [10]. In contrast to
those results, IVMD was not established to predict
the clinical and echocardiographic responses in the
present study. Since factors such as changes in pre-
load and afterload, which have an impact on ventri-
cular ejection and pulmonary and systemic hyperten-
sion, alter this particular parameter, the use of
IVMD in predicting the CRT response is limited
when compared to intraventricular dyssynchrony
parameters [29].
Pulse-wave and color tissue Doppler indices
Bax et al. [30] reported that a delay of > 60 ms
between the lateral and septal walls measured on
PW tissue Doppler predicted the CRT response
with 80% accuracy. Bordachar et al. [31] demon-
strated a strong correlation between intraventri-
cular dyssynchrony observed on PW tissue Doppler
and hemodynamic variables. However, these varia-
bles do not reflect LV reverse remodeling, which
requires long-term follow-up. Soliman et al. [32],
on the other hand, concluded that PW tissue Dop-
pler measurement of the delay between the lateral
and septal walls failed to predict the clinical and
echocardiographic responses. In the present study,
this particular parameter was not associated with
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predicting clinical and echocardiographic respons-
es to CRT. PW tissue Doppler imaging is suscepti-
ble to angle-related mistakes, and does not allow
the simultaneous viewing of a regional myocardial
movement within a stroke. Furthermore, determin-
ing peak systolic velocity may be complicated in
ischemic cardiomyopathy patients. Therefore, PW
tissue Doppler appears inadequate in predicting
CRT response. This particular approach may yield
better results by increasing the number of seg-
ments analyzed [33] or by 3D analysis of the myo-
cardial velocity and deformation [34].
A number of studies have reported color tis-
sue Doppler to have high accuracy in predicting
post-CRT clinical improvement and LV reverse
remodeling [13]. Bleeker et al. [35] reported that
the delay between the lateral wall and septum mea-
sured by color tissue Doppler with a cut-off value
of 65 ms had 90% sensitivity and 82% specificity in
predicting the response to CRT. It was established
to have 52.6% sensitivity and 69.2% specificity at
a cut-off value of 60 ms in predicting LV reverse
remodeling in the PROSPECT trial [10]. This par-
ticular parameter was not observed to predict the
clinical or echocardiographic response to CRT in the
present study. However, it should be noted that
intraventricular dyssynchrony was determined by
using two segments of the left ventricle (the basal
portions of the septum and lateral wall). Since this
particular model did not evaluate the ventricle in
its entirety, the longest delay between the seg-
ments might not have been determined. Studies
employing models with four or 12 segments have
reported higher rates of accuracy in predicting the
response to CRT [13, 36].
Limitations of the study
There were a few significant limitations to our
study. The number of patients enrolled was rela-
tively small. Our data should be supported by lar-
ger studies in order to decrease the probability of
randomness in the results. The follow-up period
was limited to six months; long-term results are
unknown. The inter-observer correlation coeffi-
cients were relatively low, and corresponding vari-
abilities were high for indices of dyssynchrony. LV
dyssynchrony is a 3D and complex issue involving
ventricular electrical activation, the distribution of
myocardial fibers, and the torsion forces on those
fibers. Therefore, 3D echocardiography or using pa-
rameters evaluating radial and circumferential dys-
synchrony may be a better approach. We could not
examine those characteristics because echocardio-
graphy software including novel imaging approach-
es such as tissue synchronization imaging, 2D strain,
and 3D echocardiography were not available.
Another limitation of the study was the pre-
sence of extensive scar tissue in ischemic patients
which may have resulted in decreased clinical and
echocardiographic response rates despite dyssynchro-
ny. The use of magnetic resonance imaging along with
echocardiography may be beneficial in determining
the presence of scar tissue, as well as its localization
and size, when selecting patients for CRT.
Conclusions
CRT has become a well-established therapeu-
tic option for patients with HF and LV dyssynchro-
ny. Despite recent advances in non-invasive evalu-
ation methods, most current indices do not ade-
quately identify responders to CRT. Prolonged
APEI reflects delayed LV activation, LV dyssyn-
chrony and ejection. Our data revealed that APEI,
which can be measured in almost all patients eva-
luated by transthoracic echocardiography, could pre-
dict LV reverse remodeling and clinical response
following CRT. The assessment of this parameter
could therefore help to predict responders to CRT.
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